Related Experiment Video
Updated: May 17, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Advancement of scientific research on Helicobacter pylori in humans: where do we stand?
S A H Andrabi1, H Shamila, S Masooda
1Department of Internal Medicine, Mig colony, Bemina, Srinar, J&K, India. syed.arshadhussain@yahoo.co.in
Abstract:
Helicobacter pylori (H. pylori) has been associated with humans for millions of years and its association wih gastroduodenal diseases has well been established. Research explosion has added vastly to the current dimensions. The new and unusual pattern of involvement in the form of diffuse duodenal nodular lymphoid hyperplasia (DDNLH) due to specific strain of H. pylorii has been reported from Kashmir recently, which heckles early recognition and treatment and on the other hand, we continue to face challenges so far as the prevention of carcinoma of stomach, a worst sequlae of H. pylori is concerned although population screening and prevention surveys are underway in many countries. Continued scientific work has now unfolded involvement of H.pylori in extragastric diseases like cerebrovascular, cardiovascular, idiopathic thrombocytopenia, sideroblastic anaemia, mental diseases, and collagen vascular disease .Moreover the beneficial effects of H. pylori with respect to allergic diseases and obesity are clear. Problem of drug resistance for eradication of H. pylori has arisen for which novel treatments are tried. Lactobacillus reuteri having ant H.pylori action is one of the promising treatment as is now available in India for usage. The main challenges which remain are prevention of H. pylori related diseases by effective treatment and screening procedures and development of a vaccine which can address all these issues including beneficial aspects of H. pylori.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.